Get App
PRE MARKET
Gift Nifty indicates a positive start for the broader index in India, with a gain of 78.50 points or 0.31 percent. The Nifty futures were trading aroundthe 25,732 level.
US stocks rebounded on Wednesday as jitters over inflated tech stock valuations abated and upbeat earnings and better-than-expected economic data fueled investors’ risk appetite.
The Dow Jones Industrial Average rose 225.76 points, or 0.48%, to 47,311.00, the S&P 500 gained 24.74 points, or 0.37%, to 6,796.29, and the Nasdaq Composite climbed 151.16 points, or 0.65%, to 23,499.80.
Asia shares rose on Thursday, reversing a steep selloff from the previous session after better-than-expected U.S. economic data drew investors back into markets trading near record highs.
Japan’s Nikkei, Hong Kong’s Hang Seng, and the Taiwanese weighted index went up 0.94, 0.9,2 and 0.83 percent, respectively.
STOCKS TODAY
Mahindra and Mahindra
The company is likely to sell its entire 3.45% stake in the bank, with the block size likely at $78 million (Rs 682 crore) and a floor price of Rs 317 per share.
Tata Consultancy Services
The IT services, consulting, and business solutions company has expanded its 18-year partnership with ABB to modernize ABB’s global hosting operations, simplify its IT landscape, and strengthen its digital foundation to drive resilience and innovation.
Zydus Lifesciences
The company has received an Establishment Inspection Report (EIR) from the USFDA (US Food and Drug Administration) for its manufacturing facility in SEZ II, Ahmedabad. The USFDA inspected the group’s manufacturing plant during August 11-14, 2025. The inspection was a Pre-Approval Inspection (PAI). The USFDA has concluded this inspection as closed, with no observations. The EIR has classified the facility as No Action Indicated (NAI).
Marksans Pharma
The company’s wholly owned subsidiary, Relonchem in the UK, has received marketing authorization for its product Exemestane 25mg film-coated tablets from the UK MHRA. Exemestane tablets are used to treat hormone-positive breast cancer in postmenopausal women.
Force Motors
The company reported total sales of 2,835 units in the month of October, growing 32.1% compared to 2,146 units sold in the same month last year.
Source – Moneycontrol